Definition, course, and outcome of mild cognitive impairment
Aging Neuropsychology and CognitionPublished 1 April 1996
Glenn E. Smith, Ronald C. Petersen, Joseph E. Parisi, Robert J. Ivnik, Emre Kokmen, Eric G. Tangalos
Citations187
SJR quartileQ2
SJR score0.64
SNIP0.80
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Biologic and cognitive parameters including Apolipoprotein E genotype help to differentiate MCI persons who will progress to dementia in 2-4 years from those who will remain free from dementia over this interval.
Abstract
Abstract Mild Cognitive Impairment (MCI) is a term which can be applied to a boundary area between dementia and normal aging. Criteria which reliably describe persons falling in this range of the cognitive continuum can be defined. These persons are at very high risk for developing dementia. Biologic and cognitive parameters including Apolipoprotein E genotype help to differentiate MCI persons who will progress to dementia in 2-4 years from those who will remain free from dementia over this interval.
Keywords
MedicineNeuroscience
Encyclopedia of Social WorkDiagnostic and Statistical Manual of Mental Disorders
109,983 Citations2013Janet B. W. Williams, Michael B. First
Journal of Psychiatric Research“Mini-mental state”
86,858 Citations1975Marshal F. Folstein, Susan E. Folstein +1 more
A simplified, scored form of the cognitive mental status examination, the “Mini-Mental State” (MMS) which includes eleven questions, requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
NeurologyClinical diagnosis of Alzheimer's disease
27,993 Citations1984Guy M. McKhann, David A. Drachman +4 more
The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.
Clinical Gerontologist9/Geriatric Depression Scale (GDS)
7,192 Citations1986Jerome A. Yesavage, Javaid I. Sheikh
American Journal of PsychiatryThe Global Deterioration Scale for assessment of primary degenerative dementia
5,012 Citations1982Barry Reisberg, Steven H. Ferris +2 more
The authors describe a Global Deterioration Scale for the assessment of primary degenerative dementia and delineation of its stages and have used it successfully for more than 5 years and validated it against behavioral, neuroanatomic, and neurophysiologic measures in patients with primary degeneratives dementia.
NeurologyThe Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
4,979 Citations1991Suzanne S. Mirra, Albert Heyman +9 more
The Neuropathology Task Force of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed a practical and standardized neuropathology protocol for the postmortem assessment of dementia and control subjects, which provides neuropathologic definitions of such terms as “definite Alzheimer's disease” (AD), “probable AD,” “possible AD” and “normal brain” to indicate levels of diagnostic certainty.
Proceedings of the National Academy of SciencesApolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
4,286 Citations1993Warren J. Strittmatter, Ann M. Saunders +5 more
It is demonstrated that there was a highly significant association of apolipoprotein E type 4 allele (APOE-epsilon 4) and late-onset familial Alzheimer disease.
Archives of Clinical NeuropsychologyWechsler memory scale-revised
2,113 Citations1988C. R. Reynolds, Jeffrey Powel
Developmental NeuropsychologyGenuine memory deficits in dementia
1,021 Citations1987Ellen Grober, Herman Buschke
Cued recall was better than either free recall or recognition in discriminating elderly persons with dementia from those without dementia and by itself accounted for 75 % of the variation in dementia status.
Developmental NeuropsychologyAge‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group
935 Citations1986Thomas H. Crook, Raymond T. Bartus +4 more
NeurologyMild cognitive impairment in the elderly
835 Citations1991Charles Flicker, Steven H. Ferris +1 more
It is suggested that most elderly subjects with mild cognitive deficits, as determined by clinical evaluation and objective psychological testing, will manifest the progressive mental deterioration characteristic of dementia and that psychometric predictors can be used to distinguish between benign and more significant underlying disorders in mildly impaired elderly subjects.
JAMAApolipoprotein E Status as a Predictor of the Development of Alzheimer's Disease in Memory-Impaired Individuals
761 Citations1995Ronald C. Petersen
Patients with mild cognitive impairment can be clinically defined, many members of this group progress to Alzheimer's disease, and APOE epsilon 4 allele status appears to be a strong predictor of clinical progression.
NeurologyVery mild Alzheimer's disease
476 Citations1991John C. Morris, Daniel W. McKeel +6 more
Findings indicate that even “questionable” dementia can be diagnostic for Alzheimer's disease, and because truly normal aging may be unaccompanied by neocortical senile plaques and neurofibrillary tangles, the presence of these lesions should suggest the possibility of clinically undetected Alzheimer's Disease.
Clinical NeuropsychologistMayo's older americans normative studies: WAIS-R norms for ages 56 to 97
451 Citations1992Robert J. Ivnik, James F. Malec +5 more
NeurologyNeuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
427 Citations1994David Masur, Martin J. Sliwinski +3 more
Assessment of neuropsychological performance in 317 initially nondemented elderly persons between 75 and 85 years of age and followed them for at least 4 years as part of the Bronx Aging Study found that four measures of cognitive function from the baseline assessment can identify one subgroup with an 85% probability of developing dementia over 4 years and another with a 95% likelihood of remaining free of dementia.
Mayo Clinic ProceedingsA Short Test of Mental Status: Description and Preliminary Results
346 Citations1987Emre Kokmen, James M. Naessens +1 more
This easily administered test distinguishes demented from nondemented patients, but it should not be used as the sole means of diagnosing dementia.
NeurologyMemory function in very early Alzheimer's disease
341 Citations1994Ronald C. Petersen, Glenn E. Smith +3 more
A measure of learning with facilitation of performance using cues appears to be the best discriminator at detecting very mild AD.
PubMedApolipoprotein E: risk factor for Alzheimer disease.
260 Citations1994Ming-Lun Tsai, Eric G. Tangalos +6 more
The data suggest that the APOE-epsilon 4 allele is associated with AD and that this allelic variant may be an important risk factor for susceptibility to AD in the general population.
Developmental NeuropsychologyCriteria for diagnosing age‐associated memory impairment: Proposed improvements from the field
168 Citations1989Richard C. Blackford, Asenath La Rue
JAMAApolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
133 Citations1995Ronald C. Petersen
Psychology and AgingAge-associated memory impairment diagnoses: Problems of reliability and concerns for terminology.
83 Citations1991Glenn E. Smith, Robert J. Ivnik +3 more
Objective memory criteria for diagnosing age-associated memory impairment (AAMI), age-consistent memory impairment, and late-life forgetfulness (LLF) and results suggest that the criteria for age-related diagnoses lack reliability.